$CERT

Certara, Inc. (CERT): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Certara, Inc. (CERT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001827090 0001827090 2026-06-11 2026-06-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Repor

Original reporting
Published Jun 17, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 17, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$CERT
Neutral
medium confidence
Mentioned
$CERT
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CERTNeutralMed
01

Why it matters

The key tradable element is the CFO transition timeline (Gallagher through July 14; Mohammed effective July 15) alongside the company’s reaffirmation of full-year 2026 guidance.

02

Market read

CFO succession with guidance reaffirmation can drive short-term sentiment/volatility, but the filing provides no indication of financial reporting problems.

03

What to watch

Traders may watch for any subsequent disclosures tied to internal controls, quarterly close timing, or changes in financial reporting cadence once the interim CFO takes over.

Relevance 6/10Novelty 8/10Timing: Filed June 17, 2026; interim CFO effective July 15, 2026 with Gallagher staying through July 14.

Background

Certara filed an SEC Form 8-K (Item 5.02) detailing a CFO resignation and interim CFO appointment, plus a Regulation FD disclosure via a press release.

Company-level read

Ticker impact

$CERTNeutralMedium confidence
Context

Certara disclosed CFO John E. Gallagher III’s resignation and appointed Faiz Mohammed as Interim CFO effective July 15, 2026.

Expected impact

Likely modest, sentiment-driven volatility around the transition and any subsequent guidance/controls commentary; no direct operational change disclosed.

Evidence & confidence

The filing is a primary SEC 8-K event (Item 5.02) with clear dates and roles, but it explicitly states no disagreement and does not cite accounting/operational issues.

Market effects

No sector-wide read-across; this is company-specific finance leadership continuity.

Limited; impacts primarily Nasdaq-listed Certara sentiment and trading liquidity.

Low; no international regulatory or operational catalyst described.

Counterpoint

Because the company reaffirmed full-year 2026 guidance and cited no disagreement, the market may treat this as routine succession rather than a risk event.

Key entities

  • Certara, Inc.

    Nasdaq-listed issuer filing the 8-K; disclosed CFO resignation and interim CFO appointment.

  • John E. Gallagher III

    Senior Vice President and CFO who tendered resignation; expected to continue through July 14, 2026.

  • Faiz Mohammed

    Appointed Interim CFO effective July 15, 2026; also principal financial officer and principal accounting officer.

Related articles

$CERTMed

Certara, Inc. Q2 2026 Earnings Call Summary

Certara, Inc. reported Q2 2026 updates on its shift to specialist, scientist-led sales and a divestiture of its regulatory and medical writing business. Software revenue is 53% of total, up from 40% two years ago. Full-year revenue guidance is 0% to 4%, with adjusted EBITDA margin guided at 29% to 31%. Net loss from continuing operations was $6.1M. A new $50M share repurchase was authorized.

$CERTMedAI 8/10

Certara (CERT) Q2 2026 Earnings Call Transcript

Certara (CERT) reported Q2 2026 revenue of $93.3 million, up 1% YoY, with software revenue $48.8 million (+4%) and services $44.5 million (-3%). Total bookings were $98.3 million (+1%). Adjusted EBITDA was $26.2 million (28.1% margin). 2026 guidance: revenue $367-$382 million and adjusted EPS $0.31-$0.36. The company completed a divestiture and is integrating AI, and announced NVIDIA partnership.

$CERTMed

Certara, Inc. (CERT): Results of Operations and Financial Condition

Certara, Inc. (CERT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q22026earningsreleaseex99.htm EX-99 Document Exhibit 99.1 Certara Reports Second Quarter 2026 Financial Results A ppoints Julien Perrier Chief Commercial Officer Completes previously authorized $100 million share repurchase program; Board authorizes additional $50 million

$INTCMedAI 8/10

Lip-Bu Tan Investing $12 Million of His Own Money into Intel Raise: Daniel Newman Calls It a ‘Strong Sign of Confidence’ in Chipmaker’s Future

Intel CEO Lip-Bu Tan will invest $12 million of his own money in Intel’s upsized $20 billion stock offering, according to an SEC prospectus supplement. Intel priced 210,526,315 shares at $95. The offering was raised from $15 billion. Intel reported Q2 revenue of $16.13 billion (+25% YoY) and guided Q3 revenue $15.8-$16.8 billion.

$IRENMed

Iren Won't Have to Raise Capital for Much Longer After the Horizon 1 Delivery

Iren (NASDAQ: IREN) said its Horizon 1 data center site is operational and delivered to Microsoft (NASDAQ: MSFT), following a deal for four 50-megawatt sites. Iren expects about $500 million in annual recurring revenue for five years from Horizon 1, with CEO Dan Roberts targeting delivery of Horizon 2-4 later in 2025. The company also cited $2.8 billion in new contracts and raised its 2026 ARR target to over $4 billion.